"Carcinoma, Ductal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.
Descriptor ID |
D044584
|
MeSH Number(s) |
C04.557.470.200.025.232 C04.557.470.615.132
|
Concept/Terms |
Carcinoma, Ductal- Carcinoma, Ductal
- Carcinomas, Ductal
- Ductal Carcinomas
- Ductal Carcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Ductal".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Ductal".
This graph shows the total number of publications written about "Carcinoma, Ductal" by people in this website by year, and whether "Carcinoma, Ductal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2020 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Ductal" by people in Profiles.
-
Taparra K, Fukui J, Killeen J, Sumida K, Loo LWM, Hernandez BY. Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawai'i. JAMA Netw Open. 2021 10 01; 4(10):e2128977.
-
Bronkema C, Arora S, Sood A, Dalela D, Keeley J, Borchert A, Baumgarten L, Rogers CG, Peabody JO, Menon M, Abdollah F. Rare Histological Variants of Prostate Adenocarcinoma: A National Cancer Database Analysis. J Urol. 2020 08; 204(2):260-266.
-
Thordarson G, Slusher N, Leong H, Ochoa D, Rajkumar L, Guzman R, Nandi S, Talamantes F. Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway. Breast Cancer Res. 2004; 6(4):R423-36.